Investigator Content

Category

A Research Dynamo: Avi Schroeder at Technion Israel Institute of Technology

43-year-old Technion research dynamo Avi Schroeder is on a mission—and a “phenomenon” with four startup ventures under his belt, he works furiously and relentlessly to identify a cure for cancer from elephant protein to personalizing chemotherapy. The Yeshiva graduate...

Jun Zhu, MD, PhD with Beijing University Cancer Hospital Principal Investigator for Brukinsa

Recently, BeiGene Ltd’s lymphoma treatment Brukinsa was approved by the U.S. Food and Drug Administration. This is the first time a drug developed predominantly in China by a Chinese biopharma sponsor has been approved within America. The key clinical trials...

Dr. Lyudmila Bazhenova, MD & Immuno-Oncology Clinical Investigator Discusses Adverse Events

Dr. Lyudmila Bazhenova, professor of Medicine and thoracic oncologist with the University of California San Diego, and active principal investigator in advanced immunotherapy-based clinical trials, highlights immunotherapy-related adverse events (AEs) for the Oncology...

Thomas Gajewski, MD, PhD, University of Chicago Material Contribution to Immuno-Oncology

Thomas Gajewski, MD, PhD, AbbVie Foundation Professor of Cancer Immunotherapy in the Ben May Department for Cancer Research and Professor of Pathology and Medicine at the University of Chicago, was named by the European Society for Medical Oncology (ESMO) as the...

William G. Kaelin, Jr. MD Dana-Farber Cancer Institute and 2019 Nobel Prize Winner & Live Saver

William G. Kaelin, Jr. MD won the 2019 Nobel Prize in medicine. His research findings at Dana-Farber are game-changing: a rare disorder called von Hippel Lindau syndrome, triggered when one tumor-suppressor gene called VHL mutates, makes patients more likely to...

USC Associate Professor of Ophthalmology Conducted Stem Cell Therapy Trial for AMD

In 2017, a patient named Anna Kuehl entered a clinical trial to test a stem cell remedy for macular degeneration. She had noticed a slow loss of vision in her left eye and as it gradually worsened, hope of avoiding loss of  precious sight to age-related macular...

Atlantic Health System Clinical Investigator Discusses Pancreatic Cancer Trial Results with NJ Women’s Group

Dr. Angela Alistar, medical director of GI medical oncology at Atlantic Health System’s Morristown Medical Center recently spoke at the Morristown Women in Business Monthly Meeting in November. A pioneer in pancreatic cancer research, she addressed attendees as to the...

Dr. Angela T. Alistar: A Pioneer in Gastrointestinal Cancer Research & Patient Empowerment Advocate

A board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group, Dr. Alistar is also a Medical Director of the Phase I Breakthrough Treatment Center. At the center, her research focuses on immune-oncology and cancer metabolism in...

Professor Carola Vinuesa: Recognized in Australia on the Forefront of Personalized Immunology Research

Professor Carola Vinuesa, Co-Director of the Centre for Personalised Immunology, recently became the first female researcher at the Australian National University (ANU) to be listed—an outcome of her extensive research into personalized medicine and autoimmune...

Pin It on Pinterest